Search results
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 4 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 18 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 6 days agoMore patients can fend off the disease for months or years with targeted or immune-boosting drugs,...
Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview
The Wall Street Journal· 21 hours agoMerck—known as EMD Group in the U.S.— is betting on artificial-intelligence partnerships to develop...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 2 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Ionis Pharmaceuticals (IONS) Down 0.7% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 days agoIn the first quarter, Wainua royalty revenues were $1 million. Wainua generated sales of $5 million...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 2 days agoSenderovitz is working with partners from other pharmaceutical companies, including James...
Novel AI method could improve tissue and tumour analysis
Digital Journal· 13 hours agoThe technique is described as ‘Integrative and Reference-Informed tissue Segmentation’, or IRIS.
Democrats ramp up patent fight with drug industry in bid to lower prices
Anchorage Daily News· 14 hours agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...
Angle PLC Announces Preliminary Results
Morningstar· 3 days agoPreliminary Results for the year ended 31 December 2023COMMERCIALISATION BUILDING, WITH REVENUE MORE THAN DOUBLEDNew products and services launched; and breakthrough studies completed on combined ...
